Natco Pharma submits ANDA with USFDA for Risdiplam for Oral solution

Natco Pharma today announced submission of Abbreviated New Drug Application (ANDA) with USFDA for Risdiplam for Oral Solution.

Subscribe To Our Free Newsletter

All News, Business Standard All News